Semaglutide potrebbe essere controindicato o richiedere precauzioni particolari in determinate situazioni cliniche
Its designed and marketed for chronic weight management, with clinical trials showing about a 12% sustained weight loss at 72 weeks, according to the American Journal of Managed Care
Lastly, the low reporting rate of TTOs (3.6%) represents a significant limitation of our analysis, and thus, these results require careful interpretation
Understanding your own needs and priorities will help guide the conversation with your doctor and ensure that GLP-1 therapy is the right choice for you
Studies of bariatric surgery consistently show bone density decreases of 2-10% in the first year post-procedure, with hip and spine most affected
Warnings and Precautions: Consult your doctor before use if pregnant or breastfeeding Consult your doctor if taking medications or if you have chronic health conditions Do not exceed the recommended dose Store in a cool, dry place out of reach of children